What is he best known for?
The fields of study he is best known for:
His primary areas of study are Virology, Virus, Immunology, Antibody and Retrovirus.
Vaniambadi S. Kalyanaraman combines subjects such as Molecular biology, Immune system, Adjuvant and Hiv 1 envelope with his study of Virology.
His Virus research integrates issues from Lymphoma, T cell, T-cell receptor, Leukemia and Monoclonal antibody.
His Immunology research includes themes of In vitro, Acquired immunodeficiency syndrome and Programmed cell death.
The concepts of his Antibody study are interwoven with issues in Receptor and Affinity chromatography.
His study in Retrovirus is interdisciplinary in nature, drawing from both Tropism and Antigen.
His most cited work include:
- Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS) (985 citations)
- A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia (945 citations)
- Isolation and transmission of human retrovirus (human t-cell leukemia virus) (476 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Virology, Immunology, Virus, Antibody and Molecular biology.
The study incorporates disciplines such as Acquired immunodeficiency syndrome, Immune system and Antigen in addition to Virology.
In his study, which falls under the umbrella issue of Immune system, Heterologous is strongly linked to Adjuvant.
His Virus research includes elements of Cell culture, Transfection, Reverse transcriptase, Lymphoma and Leukemia.
His work deals with themes such as Peripheral blood mononuclear cell and Intracellular, which intersect with Cell culture.
His study looks at the intersection of Molecular biology and topics like T cell with CD8.
He most often published in these fields:
- Virology (69.13%)
- Immunology (45.64%)
- Virus (45.64%)
What were the highlights of his more recent work (between 2006-2021)?
- Virology (69.13%)
- Immunology (45.64%)
- Antibody (34.90%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Virology, Immunology, Antibody, Simian immunodeficiency virus and Immune system.
His biological study focuses on Virus.
Vaniambadi S. Kalyanaraman has researched Virus in several fields, including Genetic heterogeneity, Disease and Rubella.
His work focuses on many connections between Immunology and other disciplines, such as Regimen, that overlap with his field of interest in Major histocompatibility complex, AIDS Vaccines and MHC class I.
His work on Antigenicity, Immunogen, Neutralization and Epitope is typically connected to Coronavirus as part of general Antibody study, connecting several disciplines of science.
His Immune system research is multidisciplinary, incorporating perspectives in Adjuvant and Vaccination.
Between 2006 and 2021, his most popular works were:
- Adjuvant-dependent Innate and Adaptive Immune Signatures of Risk of SIVmac251 Acquisition (124 citations)
- Correlation of Vaccine-Elicited Systemic and Mucosal Nonneutralizing Antibody Activities with Reduced Acute Viremia following Intrarectal Simian Immunodeficiency Virus SIVmac251 Challenge of Rhesus Macaques (116 citations)
- Replicating Adenovirus-Simian Immunodeficiency Virus (SIV) Recombinant Priming and Envelope Protein Boosting Elicits Localized, Mucosal IgA Immunity in Rhesus Macaques Correlated with Delayed Acquisition following a Repeated Low-Dose Rectal SIVmac251 Challenge (90 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Immunology, Virology, Simian immunodeficiency virus, Viremia and Immune system.
All of his Immunology and Cellular immunity, Immunity, Immunogenicity, Virus and Adjuvant investigations are sub-components of the entire Immunology study.
He does research in Virus, focusing on Lentivirus specifically.
Particularly relevant to Viral load is his body of work in Virology.
His Viremia research is multidisciplinary, relying on both Antigen presentation and Vaccination.
His research integrates issues of Antibody and Cytokine in his study of Immune system.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
